Suzetrigine for Pain After Mohs Surgery

Age: 18+
Sex: Any
Trial Phase: Phase 4
Sponsor: Baylor Research Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

To compare suzetrigine versus hydrocodone/acetaminophen for postoperative pain control following dermatologic surgery.

Who Is on the Research Team?

ST

Stan Tolkachjov, MD

Principal Investigator

Baylor Medical University Center

Are You a Good Fit for This Trial?

Inclusion Criteria

I am between 18 and 89 years old.
I have had a skin tumor treated with Mohs surgery.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants receive either suzetrigine or hydrocodone/acetaminophen for postoperative pain management following Mohs micrographic surgery

48 hours
1 visit (in-person) for surgery and initial treatment

Follow-up

Participants are monitored for safety and effectiveness, including adverse events and pain management efficacy

3 days
Follow-up assessments at 24 and 48 hours post-surgery

What Are the Treatments Tested in This Trial?

Interventions

  • Norco
  • Suzetrigine

How Is the Trial Designed?

2

Treatment groups

Active Control

Group I: ControlActive Control1 Intervention
Group II: Standard of CareActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Baylor Research Institute

Lead Sponsor

Trials
210
Recruited
205,000+